AP
Amneal Pharmaceuticals, Inc. Class A Common Stock
🇩🇪XFRA.2DTGermanyHealthcare
€14.40EURup +0.10 (+0.7%)OpenEnd of day6:08 PM
Price€14.40+0.10 (+0.7%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US03168L1052
- CUSIP
- Not reported
Company
- Employees
- 8,700
- Headquarters
- Bridgewater, United States
- Website
- https://www.amneal.com
- CEO
- Mr. Chintu Patel R.Ph.
Market
- Shares outstanding
- 314.4M
- Market cap
- €4.53B
Highlights
- Market cap
- €4.53B
- EPS LTM
- $0.48
- P/E LTM
- 36.09
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.12B+9.28%up year on year
- Net income
- $157.36M+4,562.61%up year on year
- Gross margin
- 39.32%+4.39%up year on year
- Free cash flow
- $83.11M-68.34%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.